RNA polymerase II lacking a C-terminal domain (Crh) was active in transcription with purified proteins from yeast but failed to support transcription in a yeast extract. CTD dependence could be reconstituted In the purified system by addition of two fractions from the extract. An inhibitory fraction abolished transcription by both wild-type and CTD-less RNA polymerases; a stimulatory fraction restored activity of the wild-type polymerase but had a much lesser effect on the CTD-les enzyme. Parallel results were obtained with the use of a kinase inhibitor that prevents phosphorylation of the CTD by RNA polymerase I initiation factor b. The kinase inhibitor abolished transcription by wildype polymerase in yeast extract but had no scant effect in the purified system. The requirement for both the CTD and kinase action for transcription in an extract indicates that CTD phosphorylation is involved in opposing the negative effector in the extract. Factor b must play a role(s) in addition to phosphorylation of the CTD because it was still required for transcription with polymerase lacking a CTD in the purified system.
stored activity of the wild-type polymerase but had a much lesser effect on the CTD-les enzyme. Parallel results were obtained with the use of a kinase inhibitor that prevents phosphorylation of the CTD by RNA polymerase I initiation factor b. The kinase inhibitor abolished transcription by wildype polymerase in yeast extract but had no scant effect in the purified system. The requirement for both the CTD and kinase action for transcription in an extract indicates that CTD phosphorylation is involved in opposing the negative effector in the extract. Factor b must play a role(s) in addition to phosphorylation of the CTD because it was still required for transcription with polymerase lacking a CTD in the purified system. RNA polymerase II, the enzyme responsible for mRNA synthesis in eukaryotes, has much in common with other eukaryotic and bacterial RNA polymerases but is distinctive in possessing a repeated heptapeptide at the carboxy terminus of the largest subunit (1, 2) . Although the size of this C-terminal domain (CTD) varies from 26 repeats in yeast to 52 in mammals, some number of repeats is essential (a minimum of -10 in yeast), and the consensus sequence of the repeat has been conserved across species. The CTD becomes extensively phosphorylated during the initiation of transcription (3) , and the protein kinase involved has been identified as essential initiation factor b in yeast (4) (5) (6) and its homologs 8 in the rat (7, 8) and BTF2/TFIIH (9, 10) in humans. Genetic studies have indicated possible interactions of the CTD with other proteins as well (11) (12) (13) . Functions considered for the CTD include involvement in transcriptional activation (2) , a role in the transition from initiation to elongation (14) , and interaction with DNA (15) , possibly leading to the displacement of histones or of other DNA-binding proteins (2, 12) .
Biochemical studies to date have failed to clarify the role of the CTD in transcription. Some, but not all, promoters require the CTD for initiation (16) (17) (18) (19) (20) , and some, but not all, activators require the CTD for stimulation of the process (19, 21, 22) . Anti-CTD antibodies inhibit initiation both from promoters that require the CTD and from those that do not (7, 16, (23) (24) (25) . The CTD kinase is essential for initiation, but a kinase inhibitor fails to block the process (26) . Finally, cell extracts lacking SRB2 protein, an allele-specific suppressor of CTD truncations, are deficient in transcription (27) , although SRB2 protein is not required for reconstitution of the process (28).
We report here on biochemical studies of CTD function showing that some of the complexity and seeming anomalies in previous work may have to do with the transcription systems used. The CTD appears not to be required for transcription from any promoter in a basal system comprising homogeneous or highly purified components. Dependence on the CTD can be reconstituted by introduction in this basal system of multiple additional factors, opening the way to biochemical dissection of CTD function and elucidation ofits mechanism of action.
MATERIALS AND METHODS
Construction and Purification of CTD-Less RNA Polymerase U. For construction of the RPBI-Xa gene, Kpn I-BamHI and BamHI-HindIU fragments were prepared by PCR of the RPBI gene with the following primers: 5'-CCCCTGGTAC-CGGTGCATTTGATGTG-3', 5 '-CCCCGGATCCTC-GACCTTCAATTGCTTCACCATAAGCAGCAAATG-GAGACGTGGCTT-3', 5'-CCCCGGATCCTTTGGAGTC-TCCTCACCAGGCTT-3', and 5'-CCCCAAGCTTAGAA-GTTGGACGGACG-3'. The Kpn I-HindIII region of RPBI was replaced with the two PCR products to give RPBI-Xa, and an EcoRI-HindlIl fragment containing the entire gene was inserted between the EcoRI and HindIll sites of YCp5O (29) . The URA3 marker was replaced by LEU2, by insertion of aXho I (filled in)-Sal I fragment in the Sal I-Sma I region, to give YCpL5. Construction of YCpL14 was the same, except the second and third PCR primers listed above were replaced by S'-CCCCCGGATCCTGCGTAATCCGG-GACGTCGTAAGGATATGCTTCACCATAAGCAG-CAAATGG-3' and 5'-CCCCCGGATCCATTGAAGGTC-GAAT TGAAGGTCGATTTGGAGTCTCCTCAC-CAGGC-3'. YCpL5 and YCpL14 were transformed into yeast strain Z26 [a ura3-52 leu2-3 leu2-112 his3-A300 rpbl-187::HIS3/pRP112 (URA3 CEN4 RPBI), (30) ] by the lithium acetate procedure (31), followed by 5-fluoroorotic acid selection for loss ofthe plasmid-bearing wild-type RPBI.
Wild-type and mutant RNA polymerase Us were purified as described (32) 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (32) . Radioactivity in specifically initiated transcripts was quantitated and plotted as in A. (C) Effect of Bio-Rex 70 fractions on transcription in purified system. The Bio-Rex 70 column was run as described (28) . Bio-Rex flowthrough (BRFT) was prepared from the heat-treated nuclear extract described in B, and Bio-Rex 1200 mM potassium acetate eluate (BR1200) was prepared from whole-cell extract and precipisimilar CTD-less enzyme (pol II epiACTD) was (28) . Addition of the Bio-Rex flow-through fraction to the purified system abolished transcription by both CTD-less and wild-type polymerases (Fig. 2C ). Further addition of the 1200 mM potassium acetate eluate restored the reaction with the wild-type polymerase, while stimulating that with the CTD-less enzyme to a much lesser extent. The extent of stimulation by the 1200 mM potassium acetate fraction was somewhat variable, but the differential between the wild-type and CTD-less enzymes was highly reproducible. It was therefore possible to reconstitute CTD-dependent transcription in a purified system by the introduction of two fractions, one negative-acting, and the other positive-acting with specificity for the CTD.
The lack of transcriptional activity of CTD-less RNA polymerase II in a crude yeast system was in contrast with numerous reports that polymerase treated with chymotrypsin or degraded by endogenous proteases for removal ofthe CTD was fully active in HeLa nuclear extract and in partially resolved and reconstituted HeLa and Drosophila systems (16, (19) (20) (21) . The discrepancy with our findings might be explained by the retention of one or a few heptapeptide repeats in proteolyzed polymerase or by a lack of inhibitor in the HeLa extract and in the HeLa and Drosophila transcription systems used by others. To test the generality of our results, we repeated the experiments with the adenoviral major late promoter, the Schizosaccharomyces pombe ADHI promoter, and the Saccharomyces cerevisiae ADC], tated with 72% ammonium sulfate. BR1200 from nuclear extract gave similar results. Transcription was performed as in A, except that factors b and g were DEAE-5-PW fractions (28) . Symbols: filled, wild-type RNA polymerase II; open, pol IIepiACTD; circles, + BRFT; triangles, + BRFT + BR1200. [pLM] CYCI, GAL], HIS4, and PYK) promoters. In all cases, the CTD-less polymerase was active in purified but not crude transcription systems (data not shown; ADC1, GALl, and _4-a RPB1 HIS4 promoters were tested only in the purified system).
Requirement for CTD-Phosphorylation in a Crude System.
These results were extended with the use of a protein kinase inhibitor termed H8, which binds competitively with ATP (39) . H8 was shown (26) to inhibit the CTD kinase activity of factor 8, the rat homolog of yeast factor b. H8 also proved effective against factor b kinase, causing 50%1o inhibition at _ 10 ,.M (Fig. 3A) . Others (Fig. 3B) . H8 was much less inhibitory toward transcription with purified factors, and the effect in this system was attributable to inhibition of RNA polymerase rather than protein kinase, as shown by the effect of H8 on the polymerase alone (Fig. 3B ). Sensitivity to H8 was restored in the purified system by addition of the Bio-Rex flow-through fraction found previously to be involved in CTD-dependent transcription (Fig. 3C) . The Bio-Rex 1200 mM potassium acetate eluate, which reversed the effect of fractions on transcription in the purified system in the presence of kinase inhibitor H8. Transcription proteins were as described in B, except that RNA polymerase II and factor g were supplied by a
DISCUSSION
Our results extend previous investigations of the CTD in several respects. (i) The lack of CTD-dependence in a transcription system reconstituted with highly purified proteins was found for all promoters tested and may be general, in contrast with the variation among promoters reported in less well-resolved systems in the past. (ii) The restoration of CTD function by the introduction of two additional chromatographic fractions in the purified system suggests that CTD action is not direct but rather occurs through a multifactorial mechanism. The two chromatographic fractions used were crude, and extensive purification will be required to identify the particular factors involved. (iii) CTD phosphorylation is evidently part of a positive mechanism for overcoming the effect of a negative-acting component(s). This finding may resolve a paradox arising from previous studies: on the one hand, the CTD is unique to RNA polymerase II and so is unlikely to be involved in a fundamental step of the transcription process; on the other hand, evidence has been presented for a role of the CTD in the transition from transcription initiation to elongation (14) . Inhibition of transcription and its relief by a mechanism involving the CTD can accommodate both observations: the inhibitory and stimulatory factors are presumably specific for fraction from hydroxylapatite (28) containing both activities. BioRex fractions were all derived from nuclear extract. Reactions 9-16 contained 5 mM H8. BRFT, Bio-Rex flow-through.
Biochemistry: Li and Kornberg 2366 Biochemistry: Li and Kornberg RNA polymerase II transcription; and the block due to inhibition might occur at the transition to elongation. This interplay between positive and negative effectors may be a key control process in RNA polymerase II transcription.
Genetic studies have revealed several proteins, SINi (12) and SRBs (27) in particular, that interact with the CTD and that might be the negative and positive effectors of transcription identified here. Further fractionation ofthe reconstituted system will clarify their roles and identify other components involved in CTD function.
